Announcements Trials

Browse Landscape

Phase

Phase 2 7 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 49 Neoplasms 36 Prostatic Neoplasms 25 Carcinoma, Non-Small-Cell Lung 25 Polycystic Ovary Syndrome 16 Pain 15 Keratosis, Actinic 14 Leukemia 12 Colorectal Neoplasms 11 Uterine Cervical Neoplasms 10 Pancreatic Neoplasms 10 Lung Neoplasms 10 Leiomyoma 10 Carcinoma, Hepatocellular 10 Ovarian Neoplasms 9 Neoplasm Metastasis 9 Lymphoma, Follicular 9 Carcinoma, Renal Cell 9 Brain Neoplasms 9 Neuroendocrine Tumors 8 Arthritis, Rheumatoid 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Melanoma 7 Kidney Neoplasms 7 Head and Neck Neoplasms 7 Colonic Neoplasms 7 Cancer Pain 7 Multiple Myeloma 6 Lymphoma 6 Liver Neoplasms 6

Interventions

enzalutamide 1 cabazitaxel 1 Prednisone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Has results × Prostate Cancer Metastatic × Clear all

NCT02485691 2022-05-27

CARD

Sanofi

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡